Here, we report findings from in vitro loss-of-function investigations into the phenotypic effects of CRY2 knockdown on cell cycle, apoptosis, and DNA damage response to mutagen challenge in a breast cancer cell line. This evidence concerns the gene CRY2 and breast carcinoma.